The introduction of insulin therapy may improve lipid metabolism and circulating lipids, raising HDL-cholesterol and lowering triglycerides (TGs) in patients with type 2 diabetes [1, 2]. This evidence concerns the gene INS and type 2 diabetes mellitus.